OUR MISSION
Lario Therapeutics exist to change the life of patients with severe neurological disorders by developing novel precision medicines for epileptic conditions and Parkinson’s disease.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
TEAM
Henning Steinhagen, PhD, MBA
Co-founder & CEO
Tom Otis, PhD
CSO
Daniel Gill
Co-founder &
Head of Project Management
Paolo Pevarello, PhD
Head of Chemistry
Heidrun Potschka, PhD
Head of Epilepsy Pharmacology
Timothy Schulz-Utermoehl, PhD
Head of DMPK
Tim Hammond, PhD
Head of Safety
Richard Brooks, CA
Financial Director
SCIENTIFIC ADVISORY BOARD
BOARD OF DIRECTORS
Sinclair Dunlop, MBA
Investor Director, Epidarex Capital
Chiara Liberati, PhD
Investor Director, Golgi Neuroscience
Henning Steinhagen, PhD, MBA
Co-founder & CEO